Literature DB >> 18275916

Targeting tight junction proteins-significance for drug development.

Masuo Kondoh1, Takeshi Yoshida, Hideki Kakutani, Kiyohito Yagi.   

Abstract

The choice of drug target and the ability to deliver drug to those targets are pivotal in drug development. Most druggable targets are membrane proteins, such as G-protein-coupled receptors, channels and transporters. However, little attention has been paid to potential druggable targets in the membrane proteins of tight junctions (TJs), through which adjacent cell membranes contact one another. Recent progress in the cell biology of TJs provides new insights into the barrier and fence functions of TJs, suggesting that TJ components are promising candidates for drug discovery. In this review, we summarize the cell biology of TJs and discuss the TJ-based drug discovery.

Mesh:

Substances:

Year:  2008        PMID: 18275916     DOI: 10.1016/j.drudis.2007.11.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  4 in total

1.  Enteroendocrine cells are specifically marked by cell surface expression of claudin-4 in mouse small intestine.

Authors:  Takahiro Nagatake; Harumi Fujita; Nagahiro Minato; Yoko Hamazaki
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

2.  Afadin cooperates with Claudin-2 to promote breast cancer metastasis.

Authors:  Sébastien Tabariès; Alexander McNulty; Véronique Ouellet; Matthew G Annis; Mireille Dessureault; Maude Vinette; Yasmina Hachem; Brennan Lavoie; Atilla Omeroglu; Hans-Georg Simon; Logan A Walsh; Siker Kimbung; Ingrid Hedenfalk; Peter M Siegel
Journal:  Genes Dev       Date:  2019-01-28       Impact factor: 11.361

3.  Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro.

Authors:  Roberta Paolinelli; Monica Corada; Luca Ferrarini; Kavi Devraj; Cédric Artus; Cathrin J Czupalla; Noemi Rudini; Luigi Maddaluno; Eleanna Papa; Britta Engelhardt; Pierre Olivier Couraud; Stefan Liebner; Elisabetta Dejana
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 4.  Tight junctions: a barrier to the initiation and progression of breast cancer?

Authors:  Kieran Brennan; Gozie Offiah; Elaine A McSherry; Ann M Hopkins
Journal:  J Biomed Biotechnol       Date:  2009-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.